insightskies

Sphygmomanometer Market  Sphygmomanometers, popularly known as blood pressure monitors, are medical devices used to measure blood pressure non-invasively. They work on the basis of occlusion and compression of arteries by an inflatable cuff to measure blood pressure. Growing healthcare expenditure, increasing awareness about hypertension monitoring, rise in lifestyle diseases are some key factors driving the demand for affordable and accurate blood pressure monitoring devices globally. The Global Sphygmomanometer Market is estimated to be valued at US$ 3.92 Billion in 2024 and is expected to exhibit a CAGR of 9.1% over the forecast period 2024 to 2031.  Key players operating in the Sphygmomanometer Market are Omron Healthcare, ICU Medical Inc., Koninklijke Philips N.V., Baxter, Nihon Kohden, AD Medical, Spengler, SunTech Medical, Rudolf Riester GmbH, Microlife Corporation, American Diagnostic Corporation, Panasonic Healthcare, Beurer, Rossmax International Ltd., PAUL HARTMANN,...

  Medical Device Engineering Services Market The medical device engineering services market offers one-stop solutions for designing, developing, manufacturing, packaging, and servicing medical devices. It helps reduce costs by outsourcing non-core activities to specialized service providers. The market caters to diverse segments including diagnostic imaging equipment, cardiology, orthopedics, ophthalmology, respiratory care, radiology, endoscopy, and more. Medical device engineering services encompass product design and development, regulation consulting, simulation and testing, manufacturing process design, technology advisory, and quality assurance. They ensure products meet technical, functional, and safety standards before commercial launch.  The Global Medical Device Engineering Services Market is estimated to be valued at US$ 5.64 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the medi...

Transient Elastography Devices Market Transient elastography devices are medical devices that use transient elastography technology to stage liver fibrosis non-invasively. This technique utilizes ultrasound pulse to detect liver stiffness which is an indicator of the liver fibrosis stage. It has advantages like being painless, quick, and reproducible. The growing prevalence of liver diseases due to rising alcohol consumption and obesity is prompting demand for non-invasive methods of liver disease screening and diagnosis. The global transient elastography devices market is estimated to be valued at US$ 102.68 KT in 2024 and is expected to exhibit a CAGR of 1.9% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the transient elastography devices market are Echosens, HISKY Medical Technologies Co., Ltd. and SMEDA Medical Co., Ltd. Echosens owns the largest market share with its flagship product FibroScan. In recent years, these key players have focused o...

  Global Mycoplasma Testing Marke Mycoplasma testing involves screening of cell culture samples for the presence of mycoplasma contamination. Mycoplasmas are the smallest self-replicating prokaryotes, lack cell walls and known to cause chronic or degenerative diseases in animals and humans respectively. Mycoplasma testing performed to avoid contamination during production of biopharmaceuticals, helps maintaining high quality standards.   The Global Mycoplasma Testing Market is estimated to be valued at US$ 997.8 Mn in 2024 and is expected to exhibit a CAGR of 9.7% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the Global Mycoplasma Testing market are Charles River Laboratories International, Merck KGaA, Lonza Group Ltd, Roche Diagnostics, Thermo Fisher Scientific, Merck, InvivoGen, Creative Bioarray. Increased adoption of mycoplasma testing in cell culture screening and growing R&D expenditure in biopharmaceutical industry are major fac...

Medical Device Engineering Services Market The medical device engineering services market is gaining rapid popularity owing to the growing demand for advanced medical devices and technologies. Medical device engineering services help in designing, developing and testing of various medical devices across therapeutics areas. Some key services include product development and lifecycle management, regulatory and quality compliance, product upgrade services and clinical research services. With advancements in healthcare infrastructure and rising focus on patient safety, there is increasing adoption of latest medical technologies. This is driving the need for engineering consulting, prototyping and testing of various surgical, diagnostic and monitoring equipment. The global Medical Device Engineering Services Market is estimated to be valued at US$ 12.05 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the m...

  Pour Point Depressant Market Key Trends Shaping the Pour Point Depressant Market The Pour Point Depressant Market is witnessing several key trends that are reshaping the landscape of cold flow improvers in the oil and gas industry. One notable trend is the increasing demand for bio-based pour point depressants. With growing concerns about environmental sustainability and the need to reduce dependence on fossil fuels, there is a rising preference for bio-based additives derived from renewable sources. This trend reflects a broader shift towards eco-friendly solutions in the Pour Point Depressant Market. The pour point depressant market size is expected to reach US$ 2.98 Billion by 2031, from US$ 2.21 Billion in 2024, at a CAGR of 4.4% during the forecast period. Key players operating in the Pour Point Depressant Market CLARIANT, Afton Chemical, The Lubrizol Corporation, Evonik Industries, Infineum International Limited, Ecolab, Shengyang Greatwall Lubricant Oil Co.,Ltd., P...

 Minimal residual disease (MRD) testing helps detect any remaining cancer cells that may be left in the body after completion of primary treatment. It aids in determining a patient's response to therapy and guides further treatment decisions. MRD testing uses highly sensitive techniques like polymerase chain reaction (PCR), next-generation sequencing (NGS), and flow cytometry to detect presence of one cancer cell amongst 100,000 normal cells. This helps increase the chances of long-term remission and improves outcomes for cancers like acute lymphoblastic leukemia, multiple myeloma, and mantle cell lymphoma. Growing awareness about benefits of MRD monitoring and increasing prevalence of cancers globally are fueling adoption of MRD testing solutions. The global minimal residual disease testing market is estimated to be valued at US$ 4.97 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031 . Minimal Residual Disease Testing Market Key Takeaw...

Global Pediatric Perfusion Market The Global Pediatric Perfusion Market is experiencing key trends that are reshaping its landscape. One notable trend is the increasing adoption of advanced perfusion techniques and technologies in pediatric cardiac surgeries. These innovations aim to improve patient outcomes and minimize post-operative complications, driving the demand for pediatric perfusion systems globally. Moreover, the growing focus on personalized medicine and tailored perfusion strategies further accentuates the importance of the Global Pediatric Perfusion Market in addressing the unique needs of pediatric patients undergoing cardiac procedures.   The global pediatric perfusion market size was valued at US$ 574.7 Mn in 2023 and is expected to reach US$ 875.3 Mn by 2031 growing at a compound annual growth rate ( CAGR) of 5.4% from 2024 to 2031 .   Key players operating in the Global Pediatric Perfusion Market Medtronic, GE Healthcare, LivaNova, Inc., Getinge, Brail...

Bioburden Testing Market   Market Key Trends The Bioburden Testing Market is witnessing several key trends that are reshaping its landscape. One significant trend is the increasing focus on microbial quality control across various industries such as pharmaceuticals, medical devices, and food and beverages. This trend is driven by regulatory requirements and standards mandating bioburden testing to ensure product safety and compliance. Additionally, advancements in testing technologies, such as rapid microbial methods and automation, are facilitating faster and more accurate detection of microbial contamination. Moreover, the growing awareness about infection prevention and control in healthcare facilities is driving the demand for bioburden testing solutions to maintain sterile environments and minimize the risk of healthcare-associated infections. The bioburden testing Market size is valued at US$ 1.40 Bn in 2024 and is expected to reach US$ 2.59 Bn by 2031 , growing at a com...

  Global In Vitro Lung Model Market Market Drivers:   The Global In Vitro Lung Model Market is driven by several key factors. One significant driver is the increasing demand for alternatives to animal testing in biomedical research and drug development. In vitro lung models offer a more ethical and cost-effective approach for studying lung physiology, disease mechanisms, and drug responses compared to traditional animal models. Additionally, regulatory agencies such as the FDA and EMA are encouraging the adoption of in vitro models to reduce reliance on animal testing, thereby driving market growth. Moreover, advancements in tissue engineering and microfluidic technologies have led to the development of more physiologically relevant in vitro lung models, enhancing their utility in preclinical research and toxicology screening. The global in vitro lung model market size is expected to reach US$ 620.5 Mn by 2030 , from US$ 245.0 Mn in 2023 , exhibiting a CAGR of 14.2% durin...

   Global Pediatric Perfusion Market  Pediatric perfusion refers to the use of cardiopulmonary bypass during open-heart surgery in children and infants. It involves diverting a child's blood through an oxygenator and returning it to circulate through the body during surgery to correct heart defects or conditions present from birth. The demand for pediatric cardiopulmonary bypass equipment and heart-lung machines has increased significantly due to rising number of complex congenital heart diseases among newborns and infants. Pediatric perfusion equipment is specifically designed for children and carefully manages blood flow and pressure for very small patients. The Global Pediatric Perfusion Market is estimated to be valued at US$ 574.7 MN in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 to 2031 . Key Takeaways Key players operating in the Global Pediatric Perfusion Market Size are Medtronic, GE Healthcare, LivaNova, Inc., Getinge, Br...

  Global Mastopexy Market The global mastopexy market involves surgical procedures that reshape and lift sagging breasts. Some of the common procedures include breast lift with implants, breast reduction with lift, and augmentation mastopexy. Mastopexy surgery offers women better shaped and higher positioned breasts to regain a more youthful appearance. High prevalence of breast ptosis among women due to pregnancy, lactation, weight changes, and genetic predisposition has driven the demand for mastopexy procedures. Technological advancements in 3D imaging, laser mastopexy, and fat grafting techniques are expected to spur higher adoption of mastopexy treatments. The Global Mastopexy Market is estimated to be valued at US$ 2.39 BN in 2024 and is expected to exhibit a CAGR of 6.3% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Mastopexy Market Size include Allergan, Sientra, Integra, Polytech, Johnson & Johnson, Cynosure, SOLTA Medica...